GHOLAMREZA F POURZIA
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease JACKSON, CA NPI 1487635546
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CA Acerta Pharma LLC All categories
General Payments — all program years on this page
$10,082.87
- Category: General Payments
- Program years: PY2018–2024
- Record count: 578
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $221.11 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.11 | 7 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $99.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $80.84 | 4 |
| PFIZER INC. | $25.81 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15.46 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1080608984 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $5.41 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1080608987 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $10.05 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087322347 | Novartis Pharmaceuticals Corporation | $27.98 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087322353 | Novartis Pharmaceuticals Corporation | $16.30 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087322359 | Novartis Pharmaceuticals Corporation | $16.51 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087322363 | Novartis Pharmaceuticals Corporation | $20.05 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104453236 | AstraZeneca Pharmaceuticals LP | $99.00 | 04/03/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1131789573 | PFIZER INC. | $25.81 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.